Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome

British Journal of Dermatology

Volumn 157, Issue 5, 2007, Pages 1032-1036

  Antinori, S ^a   Longhi, E ^a   Bestetti, G ^a   Piolini, R ^a   Acquaviva, V ^a   Foschi, A ^a   Trovati, S ^a   Parravicini, C ^a   Corbellino, M ^a   Meroni, L ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

HAART; Human immunodeficiency virus; Immune reconstitution inflammatory syndrome; Leishmania infantum; Post kala azar dermal leishmaniasis

Indexed keywords

AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; AMPRENAVIR; AMPRENAVIR PHOSPHATE; ANTIRETROVIRUS AGENT; AZITHROMYCIN; COTRIMOXAZOLE; DIDANOSINE; EFAVIRENZ; ETHAMBUTOL; INDINAVIR; INTEGRASE INHIBITOR; L 870812; LAMIVUDINE; MILTEFOSINE; NELFINAVIR; NEVIRAPINE; PENTAMIDINE ISETHIONATE; RITONAVIR; STAVUDINE; TENOFOVIR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS PATIENT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CD4 LYMPHOCYTE COUNT; CERVICAL LYMPH NODE; DISEASE DURATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LEISHMANIA INFANTUM; MALE; MYCOBACTERIOSIS; POST KALA AZAR DERMAL LEISHMANIASIS; PRIORITY JOURNAL; SKIN LEISHMANIASIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMERICAS; ANTIPROTOZOAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASIA; HUMANS; ITALY; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; PENTAMIDINE; PHOSPHORYLCHOLINE; TRAVEL;

EID: 35348864585     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08157.x     Document Type: Article

References (19)

1. Zijlstra EE, Musa AM, Khalil EAG et al. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis 2003 3 : 87 98.
2. Shelburne SA, Visnegarwala F, Darcourt J et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005 19 : 399 406.
3. Rios-Buceta L, Buezo GF, Penas PF et al. Post-kala-azar dermal leishmaniasis in an HIV patient. Int J Dermatol 1996 35 : 303 4.
4. Roustan G, Jimenez JA, Gutierrez-Solar B et al. Post-kala-azar dermal leishmaniasis with mucosal involvement in a kidney transplant recipient: treatment with liposomal amphotericin B. Br J Dermatol 1998 138 : 526 8.
5. Ridolfo AL, Gervasoni C, Antinori S et al. Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum. J Infect 2000 40 : 199 202.
6. Dereure J, El-Safi SH, Bucheton B et al. Visceral leishmaniasis in eastern Sudan: parasite identification in humans and dogs; host-parasite relationships. Microbes Infect 2003 5 : 1103 8.
7. Stark D, Pett S, Marriott D, Harkness J. Post-kala-azar dermal leishmaniasis due to Leishmania infantum in a human immunodeficiency virus type 1-infected patient. J Clin Microbiol 2006 44 : 1178 80.
8. Boumis E, Chinello P, Della Rocca C et al. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient. Int J STD AIDS 2006 17 : 351 3.
9. Rihl M, Stoll M, Ulbricht K et al. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe. J Infect 2006 53 : e25 7.
10. Alsina-Gilbert M, Lopez-Lerma I, Herrero-Mateu C. Cutaneous manifestations of visceral leishmaniasis resistant to liposomal amphotericin B in an HIV-positive patient. Arch Dermatol 2006 142 : 787 9.
11. Puig L, Pradinaud R. Leishmania and HIV coinfection: dermatological manifestations. Ann Trop Med Parasitol 2003 97 : S107 14.
12. Agostoni C, Dorigoni N, Malfitano A et al. Mediterranean leishmaniasis in HIV-infected patients. Epidemiological, clinical and diagnostic features of 22 cases. Infection 1998 26 : 93 9.
13. Ara M, Maillo C, Peon G et al. Visceral leishmaniasis with cutaneous lesions in a patient infected with human immunodeficiency virus. Br J Dermatol 1998 139 : 114 17.
14. Calza L, D'Antuono A, Marinacci G et al. Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS. J Am Acad Dermatol 2004 50 : 461 5.
15. Gilad J, Borer A, Hallel-Halevy D et al. Post-kala-azar dermal leishmaniasis manifesting after initiation of highly active antiretroviral therapy in a patient with human immunodeficiency virus infection. Isr Med Assoc J 2001 3 : 451 2.
16. Berry A, Abraham B, Dereure J et al. Two case reports of symptomatic visceral leishmaniasis in AIDS patients concomitant with immune reconstitution due to antiretroviral therapy. Scand J Infect Dis 2004 36 : 225 7.
17. Blanche P, Gombert B, Rivoal D et al. Uveitis due to Leishmania major as part of HAART-induced immune restitution syndrome in a patient with AIDS. Clin Infect Dis 2002 34 : 1279 80.
18. Posada-Vergara MP, Lindoso JAL, Tolezano JE et al. Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS. J Infect Dis 2005 192 : 1819 22.
19. Dejenie Belay A, Asafa Y, Mesure J, Davidson RN. Successful miltefosine treatment of post-kala-azar dermal leishmaniasis occurring during antiretroviral therapy. Ann Trop Med Parasitol 2006 100 : 223 7.